Health Wire Burundi: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Burundi.

Press releases published on November 6, 2026

13 minutes ago

Anywhere Active Launches Virtual Fitness Platform for Public Libraries and Community Organizations

Indeterminate GlobeNewswire

23 minutes ago

Entera Announces Third Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

23 minutes ago

Amwell makes grant to new employees under inducement plan

Indeterminate GlobeNewswire

33 minutes ago

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

33 minutes ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

33 minutes ago

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

33 minutes ago

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

33 minutes ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2026

Indeterminate GlobeNewswire

33 minutes ago

LeMaitre to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

36 minutes ago

National Tirzepatide Online Telehealth Provider Ozari Health Launches Ozari Select Monthly Plan in All 50 States

Indeterminate GlobeNewswire

37 minutes ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

37 minutes ago

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

37 minutes ago

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

37 minutes ago

Nkarta to Host Webcast to Discuss Initial Clinical Data for NKX019 in Autoimmune Diseases at ACR Convergence 2026

Indeterminate GlobeNewswire

38 minutes ago

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

an hour ago

Wegweisende Therapie bei fortgeschrittener Herzinsuffizienz: Der wissenschaftliche Mitgründer von Repairon, Prof. Wolfram-Hubertus Zimmermann, erhält den „Galenus-von-Pergamon“-Preis 2026 für herausragende pharmakologische Grundlagenforschung

Indeterminate GlobeNewswire

an hour ago

Une approche thérapeutique innovante pour le traitement de l’insuffisance cardiaque avancée : le professeur Wolfram-Hubertus Zimmermann, cofondateur scientifique de Repairon, reçoit le prix « Galenus-von-Pergamon » 2026 pour ses travaux exceptionnels d…

Indeterminate GlobeNewswire

an hour ago

Hengrui Pharma and Braveheart Bio Present Data from 52-Week Open-Label Extension of Phase 2 Study of HRS/BHB-1893 in Obstructive Hypertrophic Cardiomyopathy at American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire

4 hours ago

Spectral Medical Inc. Announces Closing of Second Tranche of $14.0 Million Convertible Note Private Placement

Indeterminate GlobeNewswire

5 hours ago

Immunocore presents promising data from Phase 1/2 trial cohort evaluating brenetafusp plus KIMMTRAK® (tebentafusp-tebn) in metastatic uveal melanoma

Indeterminate GlobeNewswire